Form 4: Cardio Diagnostics Director Paul Burton Acquires Significant Stock Options
Insider Transaction Report
Cardio Diagnostics Holdings, Inc. Director Paul Burton reported the acquisition of 1,736 stock options with an exercise price of $3.6, effective June 30, 2025.
Summary
- Paul Frederick Burton, a Director of Cardio Diagnostics Holdings, Inc. (CDIO), acquired 1,736 stock options.
- The transaction date for the acquisition was June 30, 2025.
- Each option has an exercise price of $3.6.
- The options become exercisable on June 30, 2025, and expire on June 30, 2035.
- Following this transaction, Paul Burton beneficially owns a total of 3,394 derivative securities.
Sentiment
Score: 7
Explanation: The acquisition of stock options by a director is generally viewed positively as it aligns management's interests with shareholders and indicates confidence in future stock appreciation.
Positives
- Director Paul Burton's acquisition of 1,736 stock options indicates a potential positive outlook on the company's future performance.
- The exercise price of $3.6 per option suggests a belief in the stock's ability to trade above this price in the future, aligning management's interests with shareholder value.
Future Outlook
The acquisition of stock options by a director suggests a long-term positive outlook on the company's growth and stock performance, as the options are exercisable over a ten-year period until June 30, 2035.
Industry Context
This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.
Related Party Transactions
- The acquisition of stock options by Director Paul Burton from Cardio Diagnostics Holdings, Inc. constitutes a related party transaction, as it involves a company insider.
Stakeholder Impact
- Shareholders: The acquisition of stock options by a director can be seen as a positive signal, potentially increasing investor confidence due to alignment of interests between management and shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of earliest transaction (acquisition of stock options) and date options become exercisable. |
| 07/02/2025 | Signature date of the reporting person. |
| 06/30/2035 | Expiration date of the acquired stock options. |
Keywords
Cardio Diagnostics Holdings Inc., CDIO, SEC Form 4, Insider Transaction, Stock Options, Beneficial Ownership, Paul Burton, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.